- Home
- MRK vs DAVEW Comparison
MRK vs DAVEW Comparison
Compare MRK & DAVEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | DAVEW |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 317.8B | N/A |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MRK | DAVEW |
|---|---|---|
| Price | $148.17 | $1.15 |
| Analyst Decision | Buy | |
| Analyst Count | 17 | 0 |
| Target Price | ★ $125.59 | N/A |
| AVG Volume (30 Days) | ★ 5.8M | 43.6K |
| Earning Date | 04-30-2026 | 03-06-2025 |
| Dividend Yield | ★ 3.06% | N/A |
| EPS Growth | 8.01 | ★ 222.91 |
| EPS | N/A | ★ 4.60 |
| Revenue | ★ $65,011,000,000.00 | $554,182,000.00 |
| Revenue This Year | $3.61 | N/A |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | ★ N/A | $0.25 |
| Revenue Growth | 1.31 | ★ 59.67 |
| 52 Week Low | $77.58 | $0.20 |
| 52 Week High | $157.00 | $4.03 |
Technical Indicators
Market Signals| Indicator | MRK | DAVEW |
|---|---|---|
| Relative Strength Index (RSI) | 58.13 | 40.36 |
| Support Level | $145.75 | $0.23 |
| Resistance Level | $152.80 | $1.15 |
| Average True Range (ATR) | 2.70 | 0.27 |
| MACD | -0.86 | -0.02 |
| Stochastic Oscillator | 59.16 | 1.03 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About DAVEW Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, short-term liquidity, fee-free banking, and financial management tools, and finding side gigs.